Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone.
暂无分享，去创建一个
J. Bono | R. Ferraldeschi | S. Chowdhury | J. D. de Bono | G. Attard | D. Bianchini | A. Omlin | C. Pezaro | D. Lorente | A. Zivi | A. Rodríguez-Vida | David Lorente | Simon Chowdhury | S. Chowdhury | D. Lorente